HNSS-
Timeline with new company details
07/13/2010
Terms of the acquisition include net profit benchmarks of $300,000 to $600,000 in the first year and $600,000 to $900,000 in the second year.
"We are pleased to announce the completion of the most important event in our Company's history. The Worldwide Wipes price points are exceptionally competitive, and its customer base is nationwide. Following several years of base-building, this acquisition represents such a quantum leap for Healthnostics that we are contemplating a name and stock symbol change that reflects the diversified nature and direction of the Company," said President Alan Grofe.
07/15/2010
As the Company refocuses its business, it is contemplating the possibility of a sale of its remaining interest in MedBioWeb Corp. MedBioWeb Corp. may more readily achieve its profit goals as an independent company and Healthnostics, through its recent acquisition, may be more able to show a substantial increase in per share earnings due to the near halving of outstanding shares.
10/12/2010
Healthnostics, Inc., (PINKSHEETS: HNSS), a medical manufacturing and biotechnology analytics company, has purchased a major manufacturer of specialty medical products. There will be an immediate positive impact on revenue and earnings commencing in the 1st Quarter of 2011. Details will be forthcoming in subsequent press releases.
"This accretive purchase directly ties into the Company's recent acquisition of World Wide Wipes Co., and it will result in even more substantial impact on our profitability and earnings per share," said Alan Grofe, president.
10/29/2010
Healthnostics, Inc. (PINKSHEETS: HNSS) announced that monthly online sales through its Worldwide Wipes Co. subsidiary have increased by more than 200 percent since it was acquired in July, and this trend is continuing.
Both the number of units sold and the price per unit increased while overhead decreased as strides were made in the reduction of shipping, packaging, and advertising costs.
11/15/2010
Healthnostics, Inc. (PINKSHEETS: HNSS) is implementing its 3-S Program of "speed, space, and specialization" by unveiling its One-Machine-One-Product concept and announced the building of three new medical product manufacturing machines based upon the same technology as its fill-and-seal MicroFill-2160 machine announced in October. When completed, the three machines along with MicroFill-2160 will take up less space and operate nearly 12 times faster than a much larger traditional machine using the same number of employees and occupying the same amount of floor space.
Due to their speed, size, and low labor intensity, each machine will be allocated a different product. This One-Machine-One-Product concept will increase efficiency and profitability by (a) requiring no changeable parts other than print plates, (b) requiring no down time for product changeovers, (c) increasing productivity through labor specialization, (d) reducing losses caused by shutdown and startup waste, and (e) eliminating production line interruptions caused by packaging changes.
As a result, management redirected its resources internally and announced plans to build three new "speed, space, and specialization" machines based upon its One-Machine-One-Product concept, a decision that will triple the Company's production capabilities
